Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Madrigal Pharmaceuticals (MDGL) Interest Coverage Ratio (2022 - 2025)

Madrigal Pharmaceuticals (MDGL) has disclosed Interest Coverage Ratio for 4 consecutive years, with 7.18 as the latest value for Q4 2025.

  • Quarterly Interest Coverage Ratio rose 62.48% to 7.18 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 13.45 through Dec 2025, up 60.36% year-over-year, with the annual reading at 13.45 for FY2025, 60.36% up from the prior year.
  • Interest Coverage Ratio for Q4 2025 was 7.18 at Madrigal Pharmaceuticals, up from 15.3 in the prior quarter.
  • The five-year high for Interest Coverage Ratio was 7.18 in Q4 2025, with the low at 90.09 in Q2 2022.
  • Average Interest Coverage Ratio over 4 years is 34.08, with a median of 29.8 recorded in 2023.
  • The sharpest move saw Interest Coverage Ratio tumbled 49.19% in 2024, then surged 67.47% in 2025.
  • Over 4 years, Interest Coverage Ratio stood at 50.71 in 2022, then skyrocketed by 41.81% to 29.51 in 2023, then skyrocketed by 35.11% to 19.15 in 2024, then skyrocketed by 62.48% to 7.18 in 2025.
  • According to Business Quant data, Interest Coverage Ratio over the past three periods came in at 7.18, 15.3, and 14.46 for Q4 2025, Q3 2025, and Q2 2025 respectively.